Ophthalmology · Zionsville, IN
NPI
1942283288
Since 2005
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
10859 Creek Way Ste 100
Zionsville, IN, 46077
Phone (317) 334-4424
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.4M
12,470 services
Medicare patients, 2024
1,284
Average age 76
Drug cost, 2024
$277K
2,199 prescriptions
Company payments, 2025
$2,069
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael A Behforouz was code J2782 (injection, avacincaptad pegol, 0.1 mg), 968 times for 12 patients. In total Michael A Behforouz billed 12,470 services in 73 codes, and Medicare paid $1.4M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-09-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2782 Injection, avacincaptad pegol, 0.1 mg | Office | 968 | 12 | $86.48 | $84K |
| 92134 Computerized Ophthalmic Imaging | Office | 855 | 413 | $26.60 | $23K |
| J0177 Injection, aflibercept hd, 1 mg | Office | 792 | 21 | $264.15 | $209K |
| 92136 Ultrasound - Nonspecific | Office | 511 | 315 | $27.54 | $14K |
| 92014 Ophthalmological E&M | Office | 509 | 508 | $76.39 | $39K |
| 99213 Office E&M - Established | Office | 498 | 345 | $57.78 | $29K |
| 67028 Intravitreal Injection | Office | 433 | 109 | $87.14 | $38K |
| 92025 Test - Miscellaneous | Office | 425 | 321 | $22.56 | $9,589 |
| 66984 Cataract Surgery | Facility | 356 | 195 | $388.55 | $138K |
| J0178 Injection, aflibercept, 1 mg | Office | 322 | 45 | $656.40 | $211K |
| 99204 Office E&M - New | Office | 227 | 227 | $100.07 | $23K |
| 66821 Cataract Surgery | Office | 170 | 132 | $232.15 | $39K |
| 92133 Computerized Ophthalmic Imaging | Office | 139 | 129 | $22.88 | $3,180 |
| J3590 Unclassified biologics | Office | 122 | 43 | $68.80 | $8,394 |
| 92083 Vision, Hearing, and Speech Services | Office | 115 | 103 | $40.94 | $4,708 |
By year: 2022 $952K for 7,577 services; 2023 $1.0M for 9,329 services; 2024 $1.4M for 12,470 services.
Medicare prescription drug claims, 2024
In 2024, the drug Michael A Behforouz prescribed most often to Medicare patients was Moxifloxacin (Moxifloxacin Hcl), with 543 prescriptions and refills. In total Michael A Behforouz wrote 2,199 Medicare prescriptions that cost $277K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Moxifloxacin Moxifloxacin Hcl | 543 | 544 | 380 | $11K |
| Prednisolone Acetate Generic | 468 | 540 | 382 | $28K |
| Latanoprost Generic | 153 | 334 | 63 | $1,765 |
| Timolol Maleate Generic | 135 | 320 | 64 | $2,702 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 102 | 197 | 33 | $1,894 |
| Erythromycin Erythromycin Base | 87 | 93 | 48 | $992 |
| Ilevro Nepafenac | 81 | 88 | 65 | $31K |
| Lumigan Bimatoprost | 50 | 90 | 18 | $25K |
| Restasis Cyclosporine | 46 | 97 | 23 | $54K |
| Brimonidine Tartrate Generic | 38 | 74 | 15 | $533 |
| Bromsite Bromfenac Sodium | 32 | 47 | 24 | $8,281 |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 29 | 29 | 22 | $240 |
| Prolensa Bromfenac Sodium | 28 | 31 | 23 | $9,798 |
| Dorzolamide Hcl Generic | 25 | 52 | Under 11 | $508 |
| Brimonidine Tartrate-Timolol Brimonidine Tartrate/Timolol | 21 | 37 | Under 11 | $2,466 |
Brand drugs: 971 claims; generic drugs: 1,228 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael A Behforouz $2,069 ($2,069 in general payments such as food, travel and fees) from 19 companies. The largest payer was Abbvie Inc. with $365.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 10 | $365 |
| Bausch & Lomb Americas Inc. BLCO | 5 | $288 |
| Amgen Inc. AMGN | 19 | $270 |
| Alcon Vision LLC ALC | 12 | $224 |
| Mallinckrodt Hospital Products Inc. | 3 | $195 |
| Glaukos Corporation GKOS | 3 | $153 |
| Astellas Pharma US Inc 4503.T | 3 | $84.9 |
| ANI Pharmaceuticals, Inc. ANIP | 4 | $78.01 |
| Harrow Eye, LLC | 3 | $70.96 |
| Genentech USA, Inc. ROG.SW | 2 | $66.82 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.